As I write this
SharePost, I am sitting on my comfortable blue micro suede couch with my right
foot wrapped in an ice pack. It is
elevated, and I am hoping the ice will make a positive difference in the
swelling and pain.
As I gaze at my funny
looking feet, I am sure of one thing.
Orencia, that worked immediately and so well for a year, has failed. The
RA Troll, sneaky creature that he is, has found a way around my med of choice.
The wonders of our
immune systems, and the wonders of biologic agents, still amaze me. I am
thankful we have biologic meds as an option for treatment, unlike the RA
warriors who lived before biologics were developed.
I see my
rheumatologist on Friday. I know Orencia
has failed because my CRP is now 28.6 and I feel it. I feel it all over my body.
I would be
hard-pressed to find a joint that is not inflamed, and the fatigue is
overwhelming.
I am sero-negative,
so my rheumy pays close attention to my CRP lab results. When I first started Orencia, a year ago in
July, my CRP was over 7. The first blood
test after I began treatment with Orencia showed my CRP to be .9! Clearly, this was the drug for me at the
time. Unfortunately, that time has
passed, and I am moving on.
My first biologic med
was Humira. That med seemed to kick in
during the fourth month of treatment. It
never lowered by CRP below 5, but it did help………….a little. After a month of
helping a bit, it stopped helping at all.
My rheumatologist did
not suggest another TNF inhibitor for me.
She moved me right on up to Orencia.
I wonder if she thinks I made antibodies to Humira. I will ask her Friday.
This Friday will
probably a long appointment. My options: another TNF inhibitor, Xeljanz,
Rituxan or Actmera. I will tell you
right now, I am not keen on Rituxan or Actemra.
I am afraid of them, and I will admit it.
I wonder if my rheumy
will let me try another TNF inhibitor. If
so, am leaning toward Simponi. If any of
you have experience with Xeljanz, Rituxan, Actemra or Simponi, please feel free
to share your experience. I would
appreciate it!
No comments:
Post a Comment